Clinical trials
Biologics clinical trials
Below are recruiting biologics clinical trials, each written for real people, not researchers. We’re tracking 622 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06817590RecruitingPhase 1
Nucleoside therapy for telomere disorders
This trial tests a nucleoside therapy (dC/dT) for people with telomere biology disorders, which cause premature aging and problems like low blood counts, lung or liver issues. The goal is to see if the treatment can help manage these symptoms.
Boston, MassachusettsAges 1–70 - NCT06012019Recruiting
Gum Disease and Inflammation Study
This study looks at gum disease (periodontitis and gingivitis) and inflammation using blood and dental samples. It may help researchers understand how inflammation affects gum health.
Ivry-sur-SeineAges 18 years+ - NCT07852338RecruitingPhase 3
a Prospective, Multicenter, Randomized Controlled Trial, With a Non-randomized Sentinel Cohort, Evaluating the Efficacy of Bioxheal, a Single-layer Placental-derived Biologic in Nonhealing Diabetic Foot Ulcers
Boardman, OhioAges 18 years+ - NCT05645055Recruiting
Biologic treatment for bowel narrowing in Crohn’s disease
This trial studies biologic medicines to treat Crohn’s disease that causes bowel narrowing (“strictures”) without needing immediate surgery. It may help reduce symptoms and complications by targeting the immune-driven inflammation behind the narrowing.
Nanjing, JiangsuAges 16–65 - NCT07362693Recruiting
Biologic drugs for allergic bronchopulmonary aspergillosis with asthma
This study tests if biologic drugs are safe and effective for people with allergic bronchopulmonary aspergillosis (ABPA) who also have severe asthma. It may help if you've had an asthma attack in the past year.
Jinan, ShandongAges 18 years+ - NCT06962020Recruiting
Choosing the best first biologic for moderate to severe colitis
This study compares two first-line biologic drugs for moderate to severe ulcerative colitis to see which works better and why. The goal is to help find the best biologic treatment for each patient.
Shanxi, Xi'anAges 18–70 - NCT06444503Recruiting
A study collecting samples from children with bone problems
This study collects blood and tissue samples from children with bone or growth plate problems to build a research database. It aims to better understand these conditions and may help improve future treatments.
ToulouseAges Up to 99 years - NCT06376968Recruiting
Testing a new dialysis option for low blood pressure
This study tests a new dialysis option called 'Biologic Fusion' that may help people who often have low blood pressure during dialysis. It compares this new method to standard dialysis to see if it is safer and works better.
Bologna, Emilia-RomagnaAges 18 years+ - NCT07877727Recruiting
Enhancing the Clinical Management of CMF Through a National Pediatric and Adult Network Based on Biological and Genetic Data
AvellinoAges 4 weeks–65 years - NCT02967822Recruiting
Study of genes in MRKH syndrome and related families
This study looks at DNA (your genes) to better understand Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome. It may help researchers learn more about the condition, and it can include both people with MRKH and healthy family relatives.
ParisAges Any age - NCT03014427Recruiting
Build a hospital database of people in intensive care
This trial collects information about adults receiving intensive care to build a “database” that helps doctors and researchers better understand ICU patients. It mainly involves registering your clinical and health details, even if your condition is complex or you are getting comfort-focused care.
AachenAges 18 years+ - NCT04343443Recruiting
Test whether a lung ultrasound helps discharge planning after heart failure
This study looks at people hospitalized for worsening heart failure with weaker pumping (reduced ejection fraction). It tests whether a lung ultrasound evaluation near discharge can improve how doctors decide it is safe to send you home.
Vandœuvre-lès-NancyAges 18 years+ - NCT04343430Recruiting
Hospital study for fluid buildup in heart failure with preserved heart function
This study looks at how well doctors can assess fluid buildup before you leave the hospital if you have a type of heart failure called “preserved ejection fraction.” It may help improve decisions about when and how safely people are discharged.
Vandœuvre-lès-NancyAges 18 years+ - NCT06187870Recruiting
Biobank for urological and cancer research
This study collects blood, urine, and tissue samples from patients with urological diseases or cancers to build a biobank for future research. It may help researchers better understand these conditions and develop new treatments.
Milan, LombardyAges 18 years+ - NCT06304194Recruiting
Collecting blood and tumor samples for cancer research
This study collects and stores tumor and blood samples from children and young adults with cancer, blood disorders, or immune conditions. The samples are used to better understand these diseases and could help future treatments.
FlorenceAges birth–30 years - NCT01965132Recruiting
Biologic and targeted therapy registry for arthritis patients
This registry is collecting information about people with rheumatoid arthritis, ankylosing spondylitis, or psoriatic arthritis who are starting or needing biologic or targeted medicines. It may help researchers better understand how these treatments work in real life.
SeoulAges 18 years+ - NCT06362122Recruiting
Severe nasal polyps: links between symptoms, tissue, and blood
This study looks at people with severe nasal polyps that need surgery (ethmoidectomy) for the first time. Researchers want to understand the connection between your symptoms, nasal tissue, and blood tests.
PoitiersAges 18 years+ - NCT07823842Recruiting
Biologics for asthma and COPD
This study looks at how well medicines called biologics work for people with asthma or COPD. Biologics are special shots that target certain parts of the immune system to reduce inflammation. Researchers want to see if these treatments can help control symptoms and prevent flare-ups.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07773051Recruiting
Synthetic vascular graft for dialysis access
This trial tests a new synthetic blood vessel graft that connects an artery to a vein in your arm to create a reliable spot for dialysis. It's for people with kidney failure who need long-term dialysis but can't have the usual fistula made from their own blood vessels.
Beijing, Beijing MunicipalityAges 18–80 - NCT06314607Recruiting
Genetic study of brain lesions
This trial looks at the genetic and molecular features of brain lesions to better understand them. It may help find new ways to diagnose or treat these conditions.
ParisAges 18 years+ - NCT07731191Recruiting
Digital tools to predict Alzheimer's risk factors
This study uses smartphone tools to track early signs of Alzheimer's by analyzing risk factors. It is for people with mild cognitive issues (MCI) or subjective cognitive decline (SCD) who do not have dementia.
Brescia, BSAges 18 years+ - NCT07715435Recruiting
Collecting samples to improve echinococcosis testing
This study collects tissue and blood samples from people having surgery for echinococcosis. The samples will help develop a better PCR test (a lab test that detects the parasite) so doctors can diagnose the infection more accurately.
Alessandria, Piemonte, ItalyAges 6 years+ - NCT07596576Recruiting
Slowing aging through comprehensive health screening and interventions
This study helps healthy older adults understand their biological age—how old your body actually is—and tests personalized interventions to help you age more slowly and stay healthier longer. Researchers will perform detailed health assessments and then guide you through targeted treatments based on your individual aging profile.
Ramat Gan, Tel AvivAges 50 years+ - NCT07579845Recruiting
Dietary supplement study on aging markers and body health
This study tests whether a dietary supplement containing humic and fulvic acids (natural compounds) can improve markers of biological aging, inflammation, and how your body handles toxins. Researchers will check blood samples to see if the supplement affects these markers over time.
Richmond, VirginiaAges 40 years+
Hear when a new Biologics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for biologics?
- Yes. Clin2 currently lists 622 recruiting biologics studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a biologics trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a biologics trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.